Evotec achieves milestone in drug discovery collaboration with Ono

15-Jan-2013 - Germany

Evotec AG announced that a compound identified and optimised in a research collaboration with Ono Pharmaceutical Co., Ltd.  has been nominated to enter pre-clinical development, leading to the payment of an agreed milestone.

This collaboration project was initiated in March 2008. Evotec combined high throughput screening and its proprietary fragment-based drug discovery platform to identify novel compounds active against a protease target, which were then further optimised with Ono to generate a candidate suitable for pre-clinical development.

Other news from the department business & finance

More news from our other portals

All FT-IR spectrometer manufacturers at a glance